15761-39-4 + 945756-47-8 = 945755-56-6 反应条件:1.1 Reagents: Diisopropylethylamine,O-(7-Azabenzotriazol-1-Yl)-N,N,N′,N′-Tetramethyluronium Hexafluorophosphate Solvents: Dimethylacetamide; 12 H,Rt1.2 Reagents: Hydrochloric Acid Solvents: Methanol,1,4-Dioxane; 1 H,70 °C 标题:4-Aryl-2-Aminopyrimidines Or 4-Aryl-2-Aminoalkylpyrimidines As Jak-2 Modulators And Their Preparation,Pharmaceutical Compositions And Use In The Treatment Of Diseases 参考文献:World Intellectual Property Organization]
= 945755-56-6 [标题:Reaction Conditions 标题:Pyrimidine Derivatives As Jak-2 Inhibitors In Combination With Other Agents And Their Preparation And Use In The Treatment Of Diseases 参考文献:World Intellectual Property Organization]
= 945755-56-6 [标题:Reaction Conditions 标题:Preparation Of N-Acylazetidine Mek Inhibitors And 4-Aryl-2-Aminopyrimidine Or 4-Aryl-2-Aminoalkylpyrimidine Jak-2 Inhibitors And Their Combinations Useful For Treating Neoplasm 参考文献:World Intellectual Property Organization
1: Verstovsek S, Tam CS, Wadleigh M, Sokol L, Smith CC, Bui LA, Song C, Clary DO, Olszynski P, Cortes J, Kantarjian H, Shah NP. Phase I evaluation of XL019, an oral, potent, and selective JAK2 inhibitor. Leuk Res. 2013 Dec 11. pii: S0145-2126(13)00425-6. doi: 10.1016/j.leukres.2013.12.006. [Epub ahead of print]
合成参考文献
参考文献:10.1016/j.bmc.2023.117561 摘要:Takarada JE, Cunha MR, Almeida VM, Vasconcelos SNS, Santiago AS, Godoi PH, Salmazo A, Ramos PZ, Fala AM, de Souza LR, Da Silva IEP, Bengtson MH, Massirer KB, Couñago RM. Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors. Bioorg Med Chem. 2024 Jan 15;98():117561. doi: 10.1016/j.bmc.2023.117561.